Split History
ETFs Holding ADXS »    ADXS Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Advaxis is a clinical stage biotechnology company engaged in the discovery, development and commercialization of proprietary Lm-LLO cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen/adjuvant fusion proteins. Co.'s Lm-LLO immunotherapy product candidate is ADXS-HPV, which is for the treatment of human papilloma virus. Co.'s other product includes: ADXS-PSA, which is designed to target the PSA associated with prostate cancer; and ADXS-HER2, which is designed for the treatment of HER2 expressing cancers, including human and canine osteosarcoma. According to our ADXS split history records, Advaxis has had 1 split.
ADXS split history picture
Advaxis (ADXS) has 1 split in our ADXS split history database. The split for ADXS took place on July 15, 2013. This was a 1 for 125 reverse split, meaning for each 125 shares of ADXS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 8 share position following the split.

When a company such as Advaxis conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the ADXS split history from start to finish, an original position size of 1000 shares would have turned into 8 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Advaxis shares, starting with a $10,000 purchase of ADXS, presented on a split-history-adjusted basis factoring in the complete ADXS split history. ADXS split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 09/25/2007
End date: 09/22/2017
Start price/share: $28.75
End price/share: $4.57
Dividends collected/share: $0.00
Total return: -84.10%
Average Annual Total Return: -16.80%
Starting investment: $10,000.00
Ending investment: $1,589.40
Years: 10.00
Date Ratio
07/15/20131 for 125
ADXS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

AEZS Split History
AFAM Split History
AFFX Split History
AGN Split History
AHPI Split History
AIMT Split History
AIQ Split History
AIRM Split History
ALBO Split History
ALKS Split History

Ocean Rig UDW Inc. (ORIG)
Mer Telemanagement Solutions Ltd. (MTSL)
Merrimack Pharmaceuticals (MACK)
Diana Containerships Inc. (DCIX)
Farmers & Merchants Bancorp, Inc. (FMAO)
Henry Schein, Inc. (HSIC)
Intuitive Surgical, Inc. (ISRG)
Diana Containerships Inc. (DCIX)
Bridgeline Digital, Inc. (BLIN)
SUPERVALU INC. (SVU)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ADXS Insider Buying

ADXS Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.